Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis

Go back to Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis
(NASDAQ: AVCO) Delayed: 0.53 --0 (-0%)
Previous Close $0.53    52 Week High
Open $23.74    52 Week Low
Day High $0.53    P/E N/A 
Day Low $0.53    EPS
Volume 2,363,294       

(NASDAQ: AVCO) Delayed: 0.53 --0 (-0%)
Previous Close $0.53    52 Week High
Open $23.74    52 Week Low
Day High $0.53    P/E N/A 
Day Low $0.53    EPS
Volume 2,363,294